| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | Chlamydia gallinacea Sachse et al. 2015 |
DSM No.: | 27451, Type strain dsm-27451 dsm27451 dsm 27451 Chlamydia gallinacea |
Strain designation: | 08-1274/3 |
Other collection no. or WDCM no.: | CSUR P3509 |
Isolated from: | cloacal swab from a chicken (Gallus gallus; Barbezieux) without clinical signs |
Country: | France |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- K. Laroucau, Anses, Maisons-Alfort, France; 08-1274/3 <- F. Vorimore and K. Laroucau, Anses, Maisons-Alfort, France; |
Genbank accession numbers: | 16S rRNA gene: GQ398026 ompA gene: GQ398033 whole genome shotgun sequence: AWUS00000000 |
Cultivation conditions: | Medium 1193 , 37°C
Obligate intracellular; cell line DSMZ ACC 57
Incubation time: 3-7 days
Complete DSMZ Media List |
Summary and additional information: | <- K. Laroucau, Anses, Maisons-Alfort, France; 08-1274/3 <- F. Vorimore and K. Laroucau, Anses, Maisons-Alfort, France;. Cloacal swab from a chicken (Gallus gallus; Barbezieux) without clinical signs. France. Type strain.. Taxonomy/description (24528, 24512). Sequence accession no. 16S rRNA gene: GQ398026, ompA gene: GQ398033, whole genome shotgun sequence: AWUS00000000. (Medium 1193, incubation time: 3-7 days, pH 7, 37°C, aerobic + 5% CO2). Obligate intracellular; cell line DSMZ ACC 57 |
Literature: | 24528, 24512 |
Risk group: | 2 (t) (classification according to German TRBA) |
Restrictions: | Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz), Category A1 Animal pathogenic organism, not exported outside Germany, Category F
|
Supplied as: | Delivery form | | Prices | | Frozen | | 470,- € | | DNA | | 370,- € | | Price Category for this culture: 5 |
Freight and handling charges will be added. See price list. Note: Freight charges for frozen dispatch will apply. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |